. Author manuscript; available in PMC: 2019 Dec 1.

Published in final edited form as: Acad Radiol. 2018 Mar 27;25(12):1588–1594. doi: 10.1016/j.acra.2018.02.027

Table 4.

Higher arterial or portal venous phase enhancement predicts moderate to poorly differentiated HCC.

	Well-differentiated Av. ± SD	Moderately to poorly differentiated Av. ± SD	p value
Arterial phase enhancement (HU)	29 ± 16	52 ± 52	0.004 ^*
PV enhancement (HU)	43 ± 19	58 ± 58	0.028 ^*
HAC	0.02 ± 0.19	0.10 ± 0.10	0.345
PVC	0.27 ± 0.34	0.37 ± 0.37	0.415
AEF	0.94 ± 0.99	0.91 ± 0.91	0.922

statistically significant difference.